GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a prominent focus in therapeutic research, largely due to its notable impact on managing diseases such as adult-onset diabetes and obesity. New research have demonstrated that more than glucose management, GLP-1 agonists offer benefits for heart function and even cogniti